Nyxoah (NYXH) FCF Margin Growth (1y) (2022 - 2026)
Nyxoah (NYXH) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 855.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1,868.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -449.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -683.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -77.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -974.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 711.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 877.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 1,481.00 |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | -140,261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,261.00 |
| Dec 31, 2025 | -113,704.00 |
| Sep 30, 2025 | 565,560.00 |
| Jun 30, 2025 | 63,952.00 |
| Mar 31, 2025 | 73,523.00 |
| Dec 31, 2024 | 426.85 Mn |
| Sep 30, 2024 | -673,475.00 |
| Jun 30, 2024 | -165,844.00 |
| Mar 31, 2024 | -241.80 Mn |
| Dec 31, 2023 | -426.96 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | -138,738.00 |
| Mar 31, 2023 | 241.82 Mn |
| Dec 31, 2022 | 256.17 Mn |
| Sep 30, 2022 | 809,468.00 |
| Jun 30, 2022 | -927,272.00 |